期刊文献+

糖尿病雷帕霉素抵抗的分子机制研究

The molecular mechanism of diabetic rapamycin resistance
下载PDF
导出
摘要 目的以APOE基因缺陷小鼠为基础建立糖尿病模型,观察其动脉硬化和蛋白表达的特点,从而揭示对雷帕霉素抵抗的分子机制。方法将雄性APOE-/-小鼠16只随机分为对照组和糖尿病组,糖尿病组给予腹腔注射STZ制备糖尿病模型,检测小鼠体重、血糖、血脂,8周后取材行主动脉根部切片,HE染色对比两组主动脉根部斑块面积,行免疫组化对比粥样斑块中mTOR表达情况,用western-blot方法测定主动脉mTOR表达情况。结果糖尿病组体重较对照组有显著下降(P<0.01),血糖血脂显著升高(P<0.01),主动脉根部斑块面积增大(P<0.01),斑块内mTOR表达下降(P<0.05),主动脉内mTOR表达下降(P<0.01)。结论糖尿病导致粥样斑块增加,斑块内及主动脉内mTOR表达下降,这可能是糖尿病雷帕霉素抵抗的分子机制之一。 Objective On the basis of the APOE gene defect mouse diabetes model,the hardening of the arteries and the characteristics of protein expression was observed to reveal the molecular mechanisms of rapamycin resistance.Methods 16 male APOE-/-mice were randomly divided into control group and diabetes group.The diabetes group was given intraperitoneal injection of STZ.The body weight,blood glucose,blood lipid,aortic root out line section and plaque area were observed.The mTOR expression of aortic root lines and atheromatous plaque were detected.Results The weight of diabetes group decreased more significantly than that of the control group(P〈0.01).The blood sugar,blood fat and plaque area of diabetes group increased more significantly than that of the control group(P〈0.01).The mTOR expression of the aortic root of diabetes group increased compared with that of the control group(P〈0.01).The mTOR expression of plaque of diabetes group decreased compared with that of the control group(P〈0.01).Conclusion Diabetes increases atheromatous plaque,the plaque inside and intraaortic mTOR expression.This may be one of the molecular mechanisms of rapamycin resistance to diabetes.
出处 《西部医学》 2016年第3期338-341,共4页 Medical Journal of West China
基金 国家自然科学基金(81170081 81500224) 全军医学科技青年培育项目(13QNP058) 四川省科技厅科技创新苗子工程培育项目(2015016)
关键词 糖尿病 人雷帕霉素靶蛋白 再狭窄 Diabetes mTOR Restenosis
  • 相关文献

参考文献20

  • 1Ohira T and Iso H. Cardiovascular disease epidemiology in Asia: an overview[J]. CireJ,2013,77: 1646-1652.
  • 2Fernando Al{onso. Current Treatment of In-Stent Restenosis [J]. Journal of the American College of Cardiology, 2014, 63 (24) :2659-2673.
  • 3Cassese S, Byrne RA, Tada T, et al. Ineidenee and predictors ofrestenosis after coronary stenting in 10,004 patients with sur- veillaneeangiography[J]. Heart, 2014,100 : 153-159.
  • 4Pate GE, Lee M, Humphries K, et al: Characterizing the spec- trum of in-stent restenosis: implications for contemporary treat- ment[J]. Can J Cardiol, 2006,22:1223-1229.
  • 5Frobert Ole, Layerqvist Bo, Carlsson Jorg, et al. Differences in restenosis rate with different drug~eluting stents in patients with and without diabetes mellitus: a report from the SCAAR(Swed- ish Angiography and Angioplasty Registry)[J]. J Am CollCar- diol, 2009, 53(18) :1660-1667.
  • 6熊伟,程金湘,章翔.哺乳动物雷帕霉素靶蛋白研究进展[J].中华神经外科疾病研究杂志,2011,10(1):85-88. 被引量:9
  • 7Wang L, Rhodes CJ, Lawrence JJ, Activation of mammalian target of rapamycin (roTOR) by insulin is associated with stimu- lation of 4EBP1 binding to dimericmTOR complex 1[J]. J Bi- olChem, 2006, 281(34): 24293-24303.
  • 8Fingar DC. Mammalian cell size is controlled by roTOR and its downstream targets $6K1 and 4EBP1/eIF4E[J]. Genes Dev, 2002, 16(12): 1472-1487.
  • 9张彦,马双陶,杨永健.糖尿病合并动脉粥样硬化小鼠模型的建立[J].中国动脉硬化杂志,2014,22(2):186-189. 被引量:7
  • 10Calkin AC,Forbes JM,Smith CM,et al. Rosiglitazone attenuates atheroselerosis in a model of insulin insufficieneyindependent of its metabolic effects[J]. ArterioselerThrombVaseBiol, 2005,25 (9) :1903- 1909.

二级参考文献15

  • 1徐梓辉,周世文,钱桂生,王艳梅,汤建林,黄永平,陈维中,徐颖,应懿.2型糖尿病合并动脉粥样硬化大鼠模型的建立[J].中国病理生理杂志,2006,22(1):205-208. 被引量:8
  • 2Qian Yang Kun-Liang Guan.Expanding mTOR signaling[J].Cell Research,2007,17(8):666-681. 被引量:51
  • 3Wang L,Harris TE,Roth RA,et al.PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding[J].J Biol Chem,2007,282(27):20036-20044.
  • 4Ma L,Chen Z,Erdjument-Bromage H,et al.Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis[J].Cell,2005,121(2):179-193.
  • 5DeYoung MP,Horak P,Sofer A,et al.Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling[J].Genes Dev,2008,22(2):239-251.
  • 6Porstmann T,Santos CR,Griffiths B,et al.SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth[J].Cell Metab,2008,8(3):224-236.
  • 7Kenneth K. Wu,Youming Huan.Diabetic atherosclerosis mouse models[J]. Atherosclerosis . 2006 (2)
  • 8J. William Phillips,Kurt G. Barringhaus,John M. Sanders,Zandong Yang,Meng Chen,Sean Hesselbacher,Ann C. Czarnik,Klaus Ley,Jerry Nadler,Ian J. Sarembock.Rosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 Diabetes[J].Circulation: Journal of the American Heart Association.2003(16)
  • 9王先酉,赵秀华,王峰,程腊梅,谭孟群.高脂饮食引起大鼠动脉血管内皮细胞衰老[J].国际病理科学与临床杂志,2010,30(2):118-122. 被引量:11
  • 10林坚,刘惠霞,谭宁,邓春玉,林秋雄,余细勇.MIF在糖尿病性冠心病中的作用研究进展[J].国际病理科学与临床杂志,2011,31(1):59-63. 被引量:6

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部